Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Finding Key Collaborators in the Data

Posted on August 23rd, 2017 by in Pharma R&D

R&D is no longer a solely in-house process where Big Pharma researchers work diligently in secret to come up with the next blockbuster drug. Rising costs, patient needs, global trends, healthcare reform, changes in clinical development models and many other factors have altered the R&D landscape. In today’s environment, pharmaceutical firms must reach outward in order to innovate. Continue reading “Finding Key Collaborators in the Data” »

Combining Data to Find New Indications, Develop New Targets & Predict Adverse Events

Posted on August 21st, 2017 by in Pharma R&D

High-quality compound bioactivity data and information about biological pathways and potential drug targets is more readily available than ever—and in enormous amounts that are often daunting to researchers Continue reading “Combining Data to Find New Indications, Develop New Targets & Predict Adverse Events” »

Can We Apply Leadership Skills to Writing Pharmacovigilance SOPs?

Posted on August 18th, 2017 by in Pharmacovigilance

The Policies, Procedures and other Quality Documents that we use as a backbone to our daily PV activities are the fundamental references for ensuring the consistency of the execution of our activities. They also ensure adequate documentation Continue reading “Can We Apply Leadership Skills to Writing Pharmacovigilance SOPs?” »

Overcoming Commercial, Technical & Regulatory Challenges in Drug Discovery

Posted on August 16th, 2017 by in Chemistry

R&D departments find themselves having to work with budgets that seem to get tighter all the time. One of the best ways of ensuring that investments are used on projects with the greatest probability of success Continue reading “Overcoming Commercial, Technical & Regulatory Challenges in Drug Discovery” »

  1. 1
  2. 2
  3. 3